roundup

Monsanto Supporters Admit Massive Fail over Glyphosate Report Criticism

Following the release of the report Glyphosate: Unsafe On Any Plate on November 14, which revealed alarming levels of the weedkiller glyphosate in popular American foods, Monsanto supporters went in to full attack mode to protect their number one product, however this time they fell on their own swords within a matter of days.

November 28, 2016 | Source: Sustainable Pulse | by

Following the release of the report Glyphosate: Unsafe On Any Plate on November 14, which revealed alarming levels of the weedkiller glyphosate in popular American foods, Monsanto supporters went in to full attack mode to protect their number one product, however this time they fell on their own swords within a matter of days.

Last year, 17 leading global cancer experts from the World Health Organization’s International Agency for Research on Cancer (IARC) sparked a firestorm when they classified glyphosate as a class 2A “probable human carcinogen”.

On the heels of this growing controversy surrounding the safety of glyphosate, the testing report published by Food Democracy Now! and The Detox Project revealed alarming levels (5 to 1125 ppb) of glyphosate in General Mills’ Cheerios and Honey Nut Cheerios, Kellogg’s Corn Flakes, Raisin Bran and Frosted Flakes and PepsiCo’s Doritos Cool Ranch, Ritz Crackers and Stacy’s Simply Naked Pita Chips, as well as many more famous products, at levels that present significant risks according to the latest independent peer-reviewed science on glyphosate.

Fail #1: Criticism of testing methods
What happened following the publishing of ‘Glyphosate: Unsafe On Any Plate’ can only be described as a massive fail by some of Monsanto’s main supporters including Dr. Kevin Folta (University of Florida) and Dr. Michelle McGuire (Washington State University).

Folta and McGuire started the attack on the report on November 14 on Twitter, with criticism of the testing methods used, even before they understood what these were.

However, after holding an e-mail conversation with the FDA-registered Anresco Laboratories, Folta was forced to withdraw his criticism, which he had already fed to a selection of journalists across the U.S..